Failure of the peroxisome proliferator WY-14,643 to induce unscheduled DNA synthesis in rat hepatocytes following in vivo treatment
- 1 January 1988
- journal article
- research article
- Published by Oxford University Press (OUP) in Carcinogenesis: Integrative Cancer Research
- Vol. 9 (7) , 1179-1184
- https://doi.org/10.1093/carcin/9.7.1179
Abstract
Peroxisome proliferator hepatocarcinogens lack genotoxic activity in numerous in vitro assays using non-target cells which do not respond with peroxisome proliferation. Therefore, the effect of in vivo treatment with WY-14,643 on DNA repair was quantitated in rat hepatocytes, the target cell for carcinogenesis. Palmitoyl CoA oxidase and carnitine acetyltransferase activities in isolated hepatocytes were elevated by WY-14,643 (50 mg/kg/day by gavage for up to 5 consecutive days) and by WY-14,643 (0.1%) or di(2-ethylhexyl) phthalate (DEHP) (1.2%) feeding (for up to 28 days), indicating peroxisome proliferation had occurred. DNA repair as unscheduled DNA synthesis (UDS) was measured autoradiographically as net nuclear grains following thymidine incorporation in primary hepatocyte cultures. Treatment of rats with WY-14,643 (gavage or feeding) or DEHP (feeding) did not induce UDS. Addition of 2-acetylaminofluorene to replicate cultures demonstrated that WY-14,643 or DEHP treatment did not prevent repair response. Additional cultures were treated with H2O2 (0.8 mM H2O2 3 × at 1-h intervals) to evaluate the ability of UDS to detect any repair which may be induced by peroxisomal metabolism. H2O2 did not induce UDS at this concentration, nor did it prevent 2-acetylaminofluorene- induced repair. UDS was, however, observed in a separate experiment using a higher concentration of H2O2. In summary, a highly carcinogenic peroxisome proliferator did not induce UDS in the target cell for carcinogenesis in spite of peroxisome proliferation following in vivo treatment.This publication has 24 references indexed in Scilit:
- DNA damage related to increased hydrogen peroxide generation by hypolipidemic drug-induced liver peroxisomes.Proceedings of the National Academy of Sciences, 1984
- Evaluation of di‐(2‐ethylhexyl)phthalate and its major metabolites in the ames test and L5178Y mouse lymphoma mutagenicity assayEnvironmental Mutagenesis, 1983
- INFLUENCE OF INTESTINAL BACTERIA, SEX OF THE ANIMAL, AND POSITION OF THE NITRO-GROUP ON THE HEPATIC GENOTOXICITY OF NITROTOLUENE ISOMERS INVIVO1983
- Genotoxicity studies of di(2-ethylhexyl)phthalate and its metabolites in CHO cellsMutation Research/Genetic Toxicology, 1982
- Peroxisome proliferation in cultured rat hepatocytes produced by clofibrate and phthalate ester metabolitesToxicology Letters, 1982
- Detection of genotoxic carcinogens in the in vivo‐in vitro hepatocyte dna repair assayEnvironmental Mutagenesis, 1982
- Detection of unscheduled DNA synthesis in hepatocytes isolated from rats treated with genotoxic agents: an in vivo — in vitro assay for potential carcinogens and mutagensCarcinogenesis: Integrative Cancer Research, 1980
- PROPERTIES OF HYPOLIPIDEMIC PEROXISOME PROLIFERATORS IN THE LYMPHOCYTE [H-3]THYMIDINE AND SALMONELLA MUTAGENESIS ASSAYS1980
- HEPATIC PEROXISOME PROLIFERATION - INDUCTION BY BR-931, A HYPOLIPIDEMIC ANALOG OF WY-14,6431978
- Three Hypolipidemic Drugs Increase Hepatic Palmitoyl-Coenzyme A Oxidation in the RatScience, 1977